RSS

influenza vaccine

After the US CDC released the stats for the 2017–2018 influenza season, in which there were a reported 97 influenza-related paediatric deaths, GlobalData has reiterated its belief to move away from the chicken egg-based approach to flu vaccines more

News

Administration of quadrivalent flu jabs should be on the agenda for the NHS as fourth flu strain, known as ‘Japanese flu’ is becoming most prevalent in Europe, according to data and analytics company, GlobalData. more

Opinion

The BBC has reported that researchers from the University of Oxford’s Jenner Institute are seeking 500 NHS patients to test a new ‘universal’ vaccine for seasonal influenza, which may give better protection against the virus. more

News

Sanofi has announced the completion of its acquisition of a privately-held US vaccines biotech company, Protein Sciences, following Federal Trade Commission approval. more

News

According to research recently published by Research Nester, the global influenza vaccine market is expected to reach $45.25 billion by 2021. more

News

Life sciences pharmaceutical clinical and bioanalytical contract solutions provider, SGS, has announced that it will use a new strain of influenza virus as a challenge agent in clinical trials. more

News

Collaboration jointly developed a new medium optimised for productivity of virus expression in EB66 cells. more

News

Seqirus, an influenza vaccine provider announced a £22.1m investment for its UK manufacturing site in Liverpool more

News

Regulatory affairs services provider ELC Group has signed up for the early-stage development of a novel vaccine targeting prevention of influenza, signalling the organisation's entry into the pharmaceutical development market. more

News

Spring watch: Novartis has announced that the US Food and Drug Administration (FDA) has licensed its manufacturing facility in Holly Springs for the production of cell-culture influenza vaccines. more

News